Collaboration between Dynamic Extractions, GlaxoSmithKline, Pfizer and Brunel University winsTechnology Strategy Board’s High Value Manufacturing Grant
A consortium involving Dynamic Extractions, GlaxoSmithKline, Pfizer and Brunel University has been awarded a grant by the Technology Strategy Board (TSB) as part of the 2009 High Value Manufacturing Competition.
The project, entitled ‘Scalable Technology for the Extraction of Pharmaceuticals (STEP)’, involves the use of the separation technique High-Performance Counter Current Chromatography (HPCCC) which is being developed by Dynamic Extractions, an SME originally spun out by Brunel University.
The project intends to develop small footprint, versatile, purification instrumentation and methodology which can be operated seamlessly at a range of scales, from laboratory to kilo/pilot scale in both batch and continuous modes. The consortium will address major production challenges aiming to provide a flexible, low capital capability driving substantial cost efficiency in both drug development and drug manufacturing processes.
Posted: 26-Aug-2010
For more information, contact us at:
www.dynamicextractions.com
Address: 890, Plymouth Rd, , Slough, , Berkshire
Phone: +44 (0)1753 696979
Email: info@dynamicextractions.com